nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.118	0.197	CbGbCtD
Atropine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.111	0.185	CbGbCtD
Atropine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.111	0.185	CbGbCtD
Atropine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.1	0.167	CbGbCtD
Atropine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0839	0.14	CbGbCtD
Atropine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0758	0.127	CbGbCtD
Atropine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000862	0.0935	CbGeAlD
Atropine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000761	0.0826	CbGeAlD
Atropine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000682	0.074	CbGeAlD
Atropine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000657	0.0712	CbGeAlD
Atropine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000533	0.0578	CbGeAlD
Atropine—CHRM4—brain—acquired immunodeficiency syndrome	0.000521	0.0566	CbGeAlD
Atropine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000513	0.0557	CbGeAlD
Atropine—CHRM5—brain—acquired immunodeficiency syndrome	0.000408	0.0442	CbGeAlD
Atropine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000385	0.0418	CbGeAlD
Atropine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00103	CcSEcCtD
Atropine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00102	CcSEcCtD
Atropine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00102	CcSEcCtD
Atropine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00101	CcSEcCtD
Atropine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000373	0.00101	CcSEcCtD
Atropine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000373	0.00101	CcSEcCtD
Atropine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000371	0.00101	CcSEcCtD
Atropine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.001	CcSEcCtD
Atropine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.001	CcSEcCtD
Atropine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.001	CcSEcCtD
Atropine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.001	CcSEcCtD
Atropine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00037	0.001	CcSEcCtD
Atropine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00037	0.001	CcSEcCtD
Atropine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00037	0.001	CcSEcCtD
Atropine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.001	CcSEcCtD
Atropine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000368	0.000996	CcSEcCtD
Atropine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.000995	CcSEcCtD
Atropine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000367	0.000995	CcSEcCtD
Atropine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.000993	CcSEcCtD
Atropine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000366	0.000993	CcSEcCtD
Atropine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000366	0.0397	CbGeAlD
Atropine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000364	0.000987	CcSEcCtD
Atropine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000364	0.000987	CcSEcCtD
Atropine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.000987	CcSEcCtD
Atropine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.000986	CcSEcCtD
Atropine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000364	0.000985	CcSEcCtD
Atropine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.000984	CcSEcCtD
Atropine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.00098	CcSEcCtD
Atropine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000361	0.000978	CcSEcCtD
Atropine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000361	0.000978	CcSEcCtD
Atropine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000361	0.000977	CcSEcCtD
Atropine—CHRM1—lung—acquired immunodeficiency syndrome	0.00036	0.039	CbGeAlD
Atropine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000359	0.000972	CcSEcCtD
Atropine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000358	0.000971	CcSEcCtD
Atropine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00097	CcSEcCtD
Atropine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.000968	CcSEcCtD
Atropine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000357	0.000968	CcSEcCtD
Atropine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000357	0.000967	CcSEcCtD
Atropine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.000966	CcSEcCtD
Atropine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000356	0.000965	CcSEcCtD
Atropine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.000965	CcSEcCtD
Atropine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.000963	CcSEcCtD
Atropine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.000961	CcSEcCtD
Atropine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000354	0.000959	CcSEcCtD
Atropine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000354	0.000957	CcSEcCtD
Atropine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000353	0.000956	CcSEcCtD
Atropine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.000955	CcSEcCtD
Atropine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000352	0.0382	CbGeAlD
Atropine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000352	0.000953	CcSEcCtD
Atropine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000352	0.000952	CcSEcCtD
Atropine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.000952	CcSEcCtD
Atropine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00095	CcSEcCtD
Atropine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.000946	CcSEcCtD
Atropine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.000944	CcSEcCtD
Atropine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000347	0.000939	CcSEcCtD
Atropine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000347	0.000939	CcSEcCtD
Atropine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000346	0.000936	CcSEcCtD
Atropine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000344	0.000931	CcSEcCtD
Atropine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000344	0.000931	CcSEcCtD
Atropine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.000931	CcSEcCtD
Atropine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000343	0.00093	CcSEcCtD
Atropine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00093	CcSEcCtD
Atropine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.000929	CcSEcCtD
Atropine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.000926	CcSEcCtD
Atropine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.000926	CcSEcCtD
Atropine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.000925	CcSEcCtD
Atropine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00034	0.000922	CcSEcCtD
Atropine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00034	0.000922	CcSEcCtD
Atropine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00092	CcSEcCtD
Atropine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00092	CcSEcCtD
Atropine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.000918	CcSEcCtD
Atropine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.000918	CcSEcCtD
Atropine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.000917	CcSEcCtD
Atropine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.000915	CcSEcCtD
Atropine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.000914	CcSEcCtD
Atropine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.000911	CcSEcCtD
Atropine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00091	CcSEcCtD
Atropine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000335	0.000908	CcSEcCtD
Atropine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.000906	CcSEcCtD
Atropine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000333	0.0361	CbGeAlD
Atropine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.0009	CcSEcCtD
Atropine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000331	0.000897	CcSEcCtD
Atropine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.000896	CcSEcCtD
Atropine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.000894	CcSEcCtD
Atropine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00033	0.000894	CcSEcCtD
Atropine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000329	0.000891	CcSEcCtD
Atropine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000329	0.00089	CcSEcCtD
Atropine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00089	CcSEcCtD
Atropine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.000888	CcSEcCtD
Atropine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.000887	CcSEcCtD
Atropine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000328	0.000887	CcSEcCtD
Atropine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.000887	CcSEcCtD
Atropine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.000883	CcSEcCtD
Atropine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000325	0.00088	CcSEcCtD
Atropine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00088	CcSEcCtD
Atropine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00088	CcSEcCtD
Atropine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000325	0.00088	CcSEcCtD
Atropine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000325	0.000879	CcSEcCtD
Atropine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.000878	CcSEcCtD
Atropine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000324	0.000878	CcSEcCtD
Atropine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.000876	CcSEcCtD
Atropine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.000875	CcSEcCtD
Atropine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000323	0.000874	CcSEcCtD
Atropine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.000872	CcSEcCtD
Atropine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.000869	CcSEcCtD
Atropine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000321	0.0348	CbGeAlD
Atropine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.000867	CcSEcCtD
Atropine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000319	0.000865	CcSEcCtD
Atropine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.000862	CcSEcCtD
Atropine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000318	0.000861	CcSEcCtD
Atropine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000318	0.000861	CcSEcCtD
Atropine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000317	0.000859	CcSEcCtD
Atropine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000316	0.000857	CcSEcCtD
Atropine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.000853	CcSEcCtD
Atropine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000315	0.000852	CcSEcCtD
Atropine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.000851	CcSEcCtD
Atropine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.000851	CcSEcCtD
Atropine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000314	0.000849	CcSEcCtD
Atropine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.000849	CcSEcCtD
Atropine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000313	0.000849	CcSEcCtD
Atropine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.000848	CcSEcCtD
Atropine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.000847	CcSEcCtD
Atropine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000313	0.000847	CcSEcCtD
Atropine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000312	0.000844	CcSEcCtD
Atropine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000312	0.000844	CcSEcCtD
Atropine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.000843	CcSEcCtD
Atropine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.000842	CcSEcCtD
Atropine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.000842	CcSEcCtD
Atropine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.000841	CcSEcCtD
Atropine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00084	CcSEcCtD
Atropine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000309	0.000837	CcSEcCtD
Atropine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000309	0.000836	CcSEcCtD
Atropine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.000836	CcSEcCtD
Atropine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.000836	CcSEcCtD
Atropine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000307	0.000831	CcSEcCtD
Atropine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000306	0.000829	CcSEcCtD
Atropine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000306	0.000828	CcSEcCtD
Atropine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000823	CcSEcCtD
Atropine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.000822	CcSEcCtD
Atropine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.000819	CcSEcCtD
Atropine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.000817	CcSEcCtD
Atropine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.000813	CcSEcCtD
Atropine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.000813	CcSEcCtD
Atropine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.000812	CcSEcCtD
Atropine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.000811	CcSEcCtD
Atropine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.000809	CcSEcCtD
Atropine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.000808	CcSEcCtD
Atropine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000298	0.0323	CbGeAlD
Atropine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.000805	CcSEcCtD
Atropine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000296	0.000803	CcSEcCtD
Atropine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000296	0.000802	CcSEcCtD
Atropine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.000801	CcSEcCtD
Atropine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.000801	CcSEcCtD
Atropine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000295	0.0008	CcSEcCtD
Atropine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000293	0.0317	CbGeAlD
Atropine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000792	CcSEcCtD
Atropine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000291	0.000788	CcSEcCtD
Atropine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.000785	CcSEcCtD
Atropine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.000782	CcSEcCtD
Atropine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000288	0.000781	CcSEcCtD
Atropine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.000781	CcSEcCtD
Atropine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.000781	CcSEcCtD
Atropine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.000779	CcSEcCtD
Atropine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.000778	CcSEcCtD
Atropine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.000778	CcSEcCtD
Atropine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.000778	CcSEcCtD
Atropine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.000778	CcSEcCtD
Atropine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000287	0.0311	CbGeAlD
Atropine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.000774	CcSEcCtD
Atropine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.000771	CcSEcCtD
Atropine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000284	0.00077	CcSEcCtD
Atropine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.000758	CcSEcCtD
Atropine—CHRM2—brain—acquired immunodeficiency syndrome	0.00028	0.0303	CbGeAlD
Atropine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000756	CcSEcCtD
Atropine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.000755	CcSEcCtD
Atropine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000279	0.0302	CbGeAlD
Atropine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.00075	CcSEcCtD
Atropine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.000749	CcSEcCtD
Atropine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.000749	CcSEcCtD
Atropine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.000745	CcSEcCtD
Atropine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000275	0.000745	CcSEcCtD
Atropine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000275	0.000744	CcSEcCtD
Atropine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.000744	CcSEcCtD
Atropine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.000743	CcSEcCtD
Atropine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.000738	CcSEcCtD
Atropine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.000738	CcSEcCtD
Atropine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.000738	CcSEcCtD
Atropine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.000736	CcSEcCtD
Atropine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.000734	CcSEcCtD
Atropine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.000728	CcSEcCtD
Atropine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.000725	CcSEcCtD
Atropine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000723	CcSEcCtD
Atropine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000722	CcSEcCtD
Atropine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000721	CcSEcCtD
Atropine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00072	CcSEcCtD
Atropine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00072	CcSEcCtD
Atropine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00072	CcSEcCtD
Atropine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.000716	CcSEcCtD
Atropine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000715	CcSEcCtD
Atropine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000715	CcSEcCtD
Atropine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000706	CcSEcCtD
Atropine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000704	CcSEcCtD
Atropine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.000696	CcSEcCtD
Atropine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000696	CcSEcCtD
Atropine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.000695	CcSEcCtD
Atropine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.000693	CcSEcCtD
Atropine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.000693	CcSEcCtD
Atropine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000256	0.000692	CcSEcCtD
Atropine—CHRM1—brain—acquired immunodeficiency syndrome	0.000255	0.0276	CbGeAlD
Atropine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.000689	CcSEcCtD
Atropine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000254	0.000687	CcSEcCtD
Atropine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000253	0.000686	CcSEcCtD
Atropine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.000683	CcSEcCtD
Atropine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000252	0.000682	CcSEcCtD
Atropine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00068	CcSEcCtD
Atropine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000674	CcSEcCtD
Atropine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.000671	CcSEcCtD
Atropine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000664	CcSEcCtD
Atropine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000244	0.0265	CbGeAlD
Atropine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.000661	CcSEcCtD
Atropine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.000661	CcSEcCtD
Atropine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.000654	CcSEcCtD
Atropine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000653	CcSEcCtD
Atropine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.000651	CcSEcCtD
Atropine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.000649	CcSEcCtD
Atropine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.000648	CcSEcCtD
Atropine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000239	0.000647	CcSEcCtD
Atropine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.000646	CcSEcCtD
Atropine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.000645	CcSEcCtD
Atropine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.000644	CcSEcCtD
Atropine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000629	CcSEcCtD
Atropine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.000626	CcSEcCtD
Atropine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000623	CcSEcCtD
Atropine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.000621	CcSEcCtD
Atropine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00062	CcSEcCtD
Atropine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00062	CcSEcCtD
Atropine—CHRM3—brain—acquired immunodeficiency syndrome	0.000228	0.0247	CbGeAlD
Atropine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.000617	CcSEcCtD
Atropine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000616	CcSEcCtD
Atropine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.000611	CcSEcCtD
Atropine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000602	CcSEcCtD
Atropine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.0006	CcSEcCtD
Atropine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000599	CcSEcCtD
Atropine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000591	CcSEcCtD
Atropine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.000585	CcSEcCtD
Atropine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000579	CcSEcCtD
Atropine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000579	CcSEcCtD
Atropine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000574	CcSEcCtD
Atropine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000573	CcSEcCtD
Atropine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000572	CcSEcCtD
Atropine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00057	CcSEcCtD
Atropine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000557	CcSEcCtD
Atropine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000553	CcSEcCtD
Atropine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000552	CcSEcCtD
Atropine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000552	CcSEcCtD
Atropine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000549	CcSEcCtD
Atropine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000541	CcSEcCtD
Atropine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000531	CcSEcCtD
Atropine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000527	CcSEcCtD
Atropine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000527	CcSEcCtD
Atropine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000524	CcSEcCtD
Atropine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00052	CcSEcCtD
Atropine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000496	CcSEcCtD
Atropine—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000117	0.00512	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000109	0.00479	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000108	0.00477	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000108	0.00473	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000107	0.00472	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000107	0.00471	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000106	0.00467	CbGpPWpGaD
Atropine—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000105	0.00461	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000104	0.00459	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000102	0.00448	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000102	0.00448	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000102	0.00448	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000102	0.00447	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000101	0.00443	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000101	0.00442	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000101	0.00442	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.95e-05	0.00438	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.86e-05	0.00434	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.74e-05	0.00428	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.66e-05	0.00425	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.63e-05	0.00423	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.58e-05	0.00421	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.55e-05	0.0042	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.53e-05	0.00419	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.46e-05	0.00416	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.45e-05	0.00415	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.33e-05	0.0041	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.27e-05	0.00408	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.27e-05	0.00408	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	9.26e-05	0.00407	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.06e-05	0.00398	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.88e-05	0.0039	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.88e-05	0.0039	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.87e-05	0.0039	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.83e-05	0.00388	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.73e-05	0.00384	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.71e-05	0.00383	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.68e-05	0.00381	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.62e-05	0.00379	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.57e-05	0.00377	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.46e-05	0.00372	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.35e-05	0.00367	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	8.21e-05	0.00361	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	8.21e-05	0.00361	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.19e-05	0.0036	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	8.19e-05	0.0036	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	8.19e-05	0.0036	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	8.11e-05	0.00356	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	8.11e-05	0.00356	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.99e-05	0.00351	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.85e-05	0.00345	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	7.76e-05	0.00341	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.61e-05	0.00335	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.35e-05	0.00323	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.33e-05	0.00322	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.26e-05	0.00319	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.05e-05	0.0031	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.99e-05	0.00307	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.76e-05	0.00297	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.65e-05	0.00292	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.63e-05	0.00291	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.57e-05	0.00289	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.57e-05	0.00289	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.55e-05	0.00288	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.48e-05	0.00285	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.36e-05	0.00279	CbGpPWpGaD
Atropine—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	6.33e-05	0.00278	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.25e-05	0.00275	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.25e-05	0.00275	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.25e-05	0.00275	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.23e-05	0.00274	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.23e-05	0.00274	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.23e-05	0.00274	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.17e-05	0.00271	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.17e-05	0.00271	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.17e-05	0.00271	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.12e-05	0.00269	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.11e-05	0.00269	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.09e-05	0.00268	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.09e-05	0.00268	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	6.03e-05	0.00265	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.96e-05	0.00262	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.94e-05	0.00261	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.88e-05	0.00258	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.63e-05	0.00247	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.61e-05	0.00247	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.6e-05	0.00246	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.57e-05	0.00245	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.56e-05	0.00244	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.55e-05	0.00244	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.55e-05	0.00244	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.52e-05	0.00243	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.51e-05	0.00242	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.45e-05	0.0024	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.38e-05	0.00237	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.36e-05	0.00236	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.35e-05	0.00235	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.35e-05	0.00235	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.34e-05	0.00235	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.24e-05	0.0023	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.24e-05	0.0023	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.13e-05	0.00225	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.13e-05	0.00225	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.06e-05	0.00223	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.02e-05	0.00221	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.02e-05	0.00221	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.85e-05	0.00213	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.84e-05	0.00213	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.76e-05	0.00209	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.76e-05	0.00209	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.76e-05	0.00209	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.74e-05	0.00208	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.7e-05	0.00206	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.63e-05	0.00204	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.56e-05	0.002	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.56e-05	0.002	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.29e-05	0.00188	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.27e-05	0.00188	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.23e-05	0.00186	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	4.08e-05	0.00179	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.99e-05	0.00175	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.93e-05	0.00173	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.82e-05	0.00168	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.77e-05	0.00166	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.76e-05	0.00165	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.76e-05	0.00165	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.76e-05	0.00165	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.75e-05	0.00165	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.73e-05	0.00164	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.71e-05	0.00163	CbGpPWpGaD
Atropine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.67e-05	0.00161	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.62e-05	0.00159	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.61e-05	0.00159	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.61e-05	0.00159	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.6e-05	0.00158	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.6e-05	0.00158	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.59e-05	0.00158	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.57e-05	0.00157	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.56e-05	0.00157	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.56e-05	0.00157	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.53e-05	0.00155	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.53e-05	0.00155	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.52e-05	0.00155	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.52e-05	0.00155	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.49e-05	0.00153	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.49e-05	0.00153	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.47e-05	0.00152	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.44e-05	0.00151	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.42e-05	0.0015	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.41e-05	0.0015	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.4e-05	0.0015	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.37e-05	0.00148	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.31e-05	0.00145	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.29e-05	0.00145	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.26e-05	0.00143	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.26e-05	0.00143	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.25e-05	0.00143	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.22e-05	0.00142	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.21e-05	0.00141	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.21e-05	0.00141	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.21e-05	0.00141	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.2e-05	0.00141	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.2e-05	0.00141	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.17e-05	0.00139	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.17e-05	0.00139	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.17e-05	0.00139	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.12e-05	0.00137	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.99e-05	0.00131	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.86e-05	0.00126	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.81e-05	0.00124	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.81e-05	0.00124	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.73e-05	0.0012	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.72e-05	0.0012	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.69e-05	0.00118	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.69e-05	0.00118	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.69e-05	0.00118	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.68e-05	0.00118	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.65e-05	0.00117	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.65e-05	0.00116	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.64e-05	0.00116	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.61e-05	0.00115	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.58e-05	0.00113	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.57e-05	0.00113	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.44e-05	0.00107	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.43e-05	0.00107	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.42e-05	0.00106	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.00106	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.00106	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.4e-05	0.00106	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.4e-05	0.00105	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.39e-05	0.00105	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.37e-05	0.00104	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.23e-05	0.00098	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.22e-05	0.000977	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.2e-05	0.000967	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.2e-05	0.000967	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.19e-05	0.000964	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000954	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.00094	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.000926	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.08e-05	0.000912	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.05e-05	0.0009	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.02e-05	0.000887	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.02e-05	0.000886	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.01e-05	0.000883	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.000875	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.99e-05	0.000874	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.000847	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.9e-05	0.000833	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.9e-05	0.000833	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.89e-05	0.000831	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.89e-05	0.000831	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.88e-05	0.000828	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.000823	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.000823	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.85e-05	0.000811	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000793	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000634	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000632	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000626	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000624	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000622	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000616	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000615	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.39e-05	0.000613	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000607	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000571	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000569	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000564	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000559	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000557	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.26e-05	0.000552	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000551	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000489	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.11e-05	0.000487	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	1.1e-05	0.000485	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000469	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000466	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.51e-06	0.00033	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.48e-06	0.000329	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.47e-06	0.000328	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.45e-06	0.000327	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.41e-06	0.000326	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.37e-06	0.000324	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.54e-06	0.000288	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.27e-06	0.000275	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.59e-06	0.000246	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.41e-06	0.000194	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.4e-06	0.000193	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.36e-06	0.000191	CbGpPWpGaD
